BSACI guideline for the management of chronic urticaria and angioedema
Identifieur interne : 002989 ( Istex/Corpus ); précédent : 002988; suivant : 002990BSACI guideline for the management of chronic urticaria and angioedema
Auteurs : R. J. Powell ; S. C. Leech ; S. Till ; P. A. J. Huber ; S. M. Nasser ; A. T. ClarkSource :
- Clinical & Experimental Allergy [ 0954-7894 ] ; 2015-03.
Abstract
This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.
Url:
DOI: 10.1111/cea.12494
Links to Exploration step
ISTEX:B0C8B3821312AA15B132DB68E888A4DEB918E679Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">BSACI guideline for the management of chronic urticaria and angioedema</title><author><name sortKey="Powell, R J" sort="Powell, R J" uniqKey="Powell R" first="R. J." last="Powell">R. J. Powell</name><affiliation><mods:affiliation>Department of Clinical Immunology and Allergy, Nottingham University, Nottingham, UK</mods:affiliation></affiliation></author><author><name sortKey="Leech, S C" sort="Leech, S C" uniqKey="Leech S" first="S. C." last="Leech">S. C. Leech</name><affiliation><mods:affiliation>Department of Child Health, Kings College Hospital, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Till, S" sort="Till, S" uniqKey="Till S" first="S." last="Till">S. Till</name><affiliation><mods:affiliation>Division of Asthma, Allergy and Lung Biology, Kings College London, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Huber, P A J" sort="Huber, P A J" uniqKey="Huber P" first="P. A. J." last="Huber">P. A. J. Huber</name><affiliation><mods:affiliation>BSACI, British Society for Allergy & Clinical Immunology, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Nasser, S M" sort="Nasser, S M" uniqKey="Nasser S" first="S. M." last="Nasser">S. M. Nasser</name><affiliation><mods:affiliation>Department of Allergy & Clinical Immunology, Addenbrooke's NHS Trust, Cambridge, UK</mods:affiliation></affiliation></author><author><name sortKey="Clark, A T" sort="Clark, A T" uniqKey="Clark A" first="A. T." last="Clark">A. T. Clark</name><affiliation><mods:affiliation>Department of Allergy, Addenbrookes NHS Trust, Cambridge, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>:Dr A. T. Clark, Allergy Clinic, Cambridge University Hospitals NHS Foundation Trust, Box 40, Cambridge CB2 2QQ, UK.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: atclark@doctors.org.uk</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B0C8B3821312AA15B132DB68E888A4DEB918E679</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1111/cea.12494</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002989</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002989</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">BSACI guideline for the management of chronic urticaria and angioedema</title><author><name sortKey="Powell, R J" sort="Powell, R J" uniqKey="Powell R" first="R. J." last="Powell">R. J. Powell</name><affiliation><mods:affiliation>Department of Clinical Immunology and Allergy, Nottingham University, Nottingham, UK</mods:affiliation></affiliation></author><author><name sortKey="Leech, S C" sort="Leech, S C" uniqKey="Leech S" first="S. C." last="Leech">S. C. Leech</name><affiliation><mods:affiliation>Department of Child Health, Kings College Hospital, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Till, S" sort="Till, S" uniqKey="Till S" first="S." last="Till">S. Till</name><affiliation><mods:affiliation>Division of Asthma, Allergy and Lung Biology, Kings College London, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Huber, P A J" sort="Huber, P A J" uniqKey="Huber P" first="P. A. J." last="Huber">P. A. J. Huber</name><affiliation><mods:affiliation>BSACI, British Society for Allergy & Clinical Immunology, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Nasser, S M" sort="Nasser, S M" uniqKey="Nasser S" first="S. M." last="Nasser">S. M. Nasser</name><affiliation><mods:affiliation>Department of Allergy & Clinical Immunology, Addenbrooke's NHS Trust, Cambridge, UK</mods:affiliation></affiliation></author><author><name sortKey="Clark, A T" sort="Clark, A T" uniqKey="Clark A" first="A. T." last="Clark">A. T. Clark</name><affiliation><mods:affiliation>Department of Allergy, Addenbrookes NHS Trust, Cambridge, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>:Dr A. T. Clark, Allergy Clinic, Cambridge University Hospitals NHS Foundation Trust, Box 40, Cambridge CB2 2QQ, UK.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: atclark@doctors.org.uk</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Clinical & Experimental Allergy</title><title level="j" type="alt">CLINICAL AND EXPERIMENTAL ALLERGY</title><idno type="ISSN">0954-7894</idno><idno type="eISSN">1365-2222</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="547">547</biblScope><biblScope unit="page" to="565">565</biblScope><biblScope unit="page-count">19</biblScope><date type="published" when="2015-03">2015-03</date></imprint><idno type="ISSN">0954-7894</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0954-7894</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>R. J. Powell</name><affiliations><json:string>Department of Clinical Immunology and Allergy, Nottingham University, Nottingham, UK</json:string></affiliations></json:item><json:item><name>S. C. Leech</name><affiliations><json:string>Department of Child Health, Kings College Hospital, London, UK</json:string></affiliations></json:item><json:item><name>S. Till</name><affiliations><json:string>Division of Asthma, Allergy and Lung Biology, Kings College London, London, UK</json:string></affiliations></json:item><json:item><name>P. A. J. Huber</name><affiliations><json:string>BSACI, British Society for Allergy & Clinical Immunology, London, UK</json:string></affiliations></json:item><json:item><name>S. M. Nasser</name><affiliations><json:string>Department of Allergy & Clinical Immunology, Addenbrooke's NHS Trust, Cambridge, UK</json:string></affiliations></json:item><json:item><name>A. T. Clark</name><affiliations><json:string>Department of Allergy, Addenbrookes NHS Trust, Cambridge, UK</json:string><json:string>:Dr A. T. Clark, Allergy Clinic, Cambridge University Hospitals NHS Foundation Trust, Box 40, Cambridge CB2 2QQ, UK.E‐mail:</json:string><json:string>E-mail: atclark@doctors.org.uk</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>adult</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>allergy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>angioedema</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>antihistamine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>anti‐IgE</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>auto‐antibody</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>autoimmune</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>breastfeeding</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>BSACI</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>child</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>epidemiology</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>guideline</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>hypothyroidism</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>IgE</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>management</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>paraprotein</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>pregnancy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>pregnancy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Urticaria</value></json:item></subject><articleId><json:string>CEA12494</json:string></articleId><arkIstex>ark:/67375/WNG-XFMDS0N2-H</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>announcement</json:string></originalGenre><abstract>This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.</abstract><qualityIndicators><refBibsNative>true</refBibsNative><abstractWordCount>149</abstractWordCount><abstractCharCount>1021</abstractCharCount><keywordCount>19</keywordCount><score>8.788</score><pdfWordCount>11289</pdfWordCount><pdfCharCount>78850</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>19</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><pdfWordsPerPage>594</pdfWordsPerPage><pdfText>true</pdfText></qualityIndicators><title>BSACI guideline for the management of chronic urticaria and angioedema</title><genre><json:string>other</json:string></genre><host><title>Clinical & Experimental Allergy</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2222</json:string></doi><issn><json:string>0954-7894</json:string></issn><eissn><json:string>1365-2222</json:string></eissn><publisherId><json:string>CEA</json:string></publisherId><volume>45</volume><issue>3</issue><pages><first>547</first><last>565</last><total>19</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>BSACI Guideline</value></json:item><json:item><value>BSACI Guidelines</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-XFMDS0N2-H</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - immunology</json:string><json:string>2 - allergy</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - allergy</json:string></scienceMetrix><scopus><json:string>1 - Life Sciences</json:string><json:string>2 - Immunology and Microbiology</json:string><json:string>3 - Immunology</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Immunology and Allergy</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2015</publicationDate><copyrightDate>2015</copyrightDate><doi><json:string>10.1111/cea.12494</json:string></doi><id>B0C8B3821312AA15B132DB68E888A4DEB918E679</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">BSACI guideline for the management of chronic urticaria and angioedema</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2015 John Wiley & Sons Ltd</licence></availability><date type="published" when="2015-03"></date></publicationStmt><notesStmt><note type="content-type" subtype="other" source="announcement" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="other"><analytic><title level="a" type="main">BSACI guideline for the management of chronic urticaria and angioedema</title><author xml:id="author-0000"><persName><forename type="first">R. J.</forename><surname>Powell</surname></persName><affiliation><orgName type="division">Department of Clinical Immunology and Allergy</orgName>
<orgName type="institution">Nottingham University</orgName>
<address><settlement>Nottingham</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">S. C.</forename><surname>Leech</surname></persName><affiliation><orgName type="division">Department of Child Health</orgName>
<orgName type="institution">Kings College Hospital</orgName>
<address><settlement>London</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">S.</forename><surname>Till</surname></persName><affiliation><orgName type="division">Division of Asthma, Allergy and Lung Biology</orgName>
<orgName type="institution">Kings College London</orgName>
<address><settlement>London</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">P. A. J.</forename><surname>Huber</surname></persName><affiliation><orgName type="division">BSACI</orgName>
<orgName type="institution">British Society for Allergy & Clinical Immunology</orgName>
<address><settlement>London</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">S. M.</forename><surname>Nasser</surname></persName><affiliation><orgName type="division">Department of Allergy & Clinical Immunology</orgName>
<orgName type="institution">Addenbrooke's NHS Trust</orgName>
<address><settlement>Cambridge</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0005" role="corresp"><persName><forename type="first">A. T.</forename><surname>Clark</surname></persName><affiliation><orgName type="division">Department of Allergy</orgName>
<orgName type="institution">Addenbrookes NHS Trust</orgName>
<address><settlement>Cambridge</settlement>
<country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><idno type="istex">B0C8B3821312AA15B132DB68E888A4DEB918E679</idno><idno type="ark">ark:/67375/WNG-XFMDS0N2-H</idno><idno type="DOI">10.1111/cea.12494</idno><idno type="unit">CEA12494</idno><idno type="toTypesetVersion">file:CEA.CEA12494.pdf</idno></analytic><monogr><title level="j" type="main">Clinical & Experimental Allergy</title><title level="j" type="alt">CLINICAL AND EXPERIMENTAL ALLERGY</title><idno type="pISSN">0954-7894</idno><idno type="eISSN">1365-2222</idno><idno type="book-DOI">10.1111/(ISSN)1365-2222</idno><idno type="book-part-DOI">10.1111/cea.2015.45.issue-3</idno><idno type="product">CEA</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="547">547</biblScope><biblScope unit="page" to="565">565</biblScope><biblScope unit="page-count">19</biblScope><date type="published" when="2015-03"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main" xml:id="cea12494-abs-0001"><head>Summary</head><p>This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (<hi rend="fc">BSACI</hi>). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all <hi rend="fc">BSACI</hi> members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.</p></abstract><textClass><keywords><term xml:id="cea12494-kwd-0001">adult</term><term xml:id="cea12494-kwd-0002">allergy</term><term xml:id="cea12494-kwd-0003">angioedema</term><term xml:id="cea12494-kwd-0004">antihistamine</term><term xml:id="cea12494-kwd-0005">anti‐IgE</term><term xml:id="cea12494-kwd-0006">auto‐antibody</term><term xml:id="cea12494-kwd-0007">autoimmune</term><term xml:id="cea12494-kwd-0008">breastfeeding</term><term xml:id="cea12494-kwd-0009"><hi rend="fc">BSACI</hi></term><term xml:id="cea12494-kwd-0010">child</term><term xml:id="cea12494-kwd-0011">epidemiology</term><term xml:id="cea12494-kwd-0012">guideline</term><term xml:id="cea12494-kwd-0013">hypothyroidism</term><term xml:id="cea12494-kwd-0014">IgE</term><term xml:id="cea12494-kwd-0015">management</term><term xml:id="cea12494-kwd-0016">paraprotein</term><term xml:id="cea12494-kwd-0017">pregnancy</term><term xml:id="cea12494-kwd-0018">pregnancy</term><term xml:id="cea12494-kwd-0019">Urticaria</term></keywords><keywords rend="articleCategory"><term>BSACI Guideline</term></keywords><keywords rend="tocHeading1"><term>BSACI Guidelines</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="cea12494" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2222</doi><issn type="print">0954-7894</issn><issn type="electronic">1365-2222</issn><idGroup><id type="product" value="CEA"></id></idGroup><titleGroup><title sort="CLINICAL AND EXPERIMENTAL ALLERGY" type="main">Clinical & Experimental Allergy</title><title type="short">Clin Exp Allergy</title></titleGroup></publicationMeta><publicationMeta level="part" position="30"><doi origin="wiley">10.1111/cea.2015.45.issue-3</doi><copyright ownership="publisher">Copyright © 2015 John Wiley & Sons Ltd</copyright><numberingGroup><numbering number="45" type="journalVolume">45</numbering><numbering type="journalIssue">3</numbering></numberingGroup><coverDate startDate="2015-03">March 2015</coverDate></publicationMeta><publicationMeta level="unit" position="30" status="forIssue" type="announcement"><doi>10.1111/cea.12494</doi><idGroup><id type="unit" value="CEA12494"></id></idGroup><countGroup><count number="19" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">BSACI Guideline</title><title type="tocHeading1">BSACI Guidelines</title></titleGroup><copyright ownership="publisher">© 2015 John Wiley & Sons Ltd</copyright><eventGroup><event date="2014-10-06" type="manuscriptReceived"></event><event date="2014-12-11" type="manuscriptRevised"></event><event date="2015-01-09" type="manuscriptAccepted"></event><event agent="SPS" date="2015-01-22" type="xmlCreated"></event><event agent="SPS" date="2015-02-27" type="xmlCorrected"></event><event type="publishedOnlineFinalForm" date="2015-02-25"></event><event type="firstOnline" date="2015-02-25"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.7.2 mode:FullText" date="2016-01-04"></event></eventGroup><numberingGroup><numbering type="pageFirst">547</numbering><numbering type="pageLast">565</numbering></numberingGroup><correspondenceTo><lineatedText><line><i>Correspondence</i>:
</line><line>Dr A. T. Clark, Allergy Clinic, Cambridge University Hospitals NHS Foundation Trust, Box 40, Cambridge CB2 2QQ, UK.</line><line>E‐mail: <email>atclark@doctors.org.uk</email></line></lineatedText></correspondenceTo><selfCitationGroup><citation type="self" xml:id="cea12494-cit-1001"><author><givenNames>R. J.</givenNames> <familyName>Powell</familyName></author>, <author><givenNames>S. C.</givenNames> <familyName>Leech</familyName></author>, <author><givenNames>S.</givenNames> <familyName>Till</familyName></author>, <author><givenNames>P. A. J.</givenNames> <familyName>Huber</familyName></author>, <author><givenNames>S. M.</givenNames> <familyName>Nasser</familyName></author> and <author><givenNames>A. T.</givenNames> <familyName>Clark</familyName></author>, <journalTitle>Clinical & Experimental Allergy</journalTitle>, <pubYear year="2015">2015</pubYear> (<vol>45</vol>) <pageFirst>547</pageFirst>–<pageLast>565</pageLast>.</citation></selfCitationGroup><objectNameGroup><objectName elementName="feature">Box</objectName></objectNameGroup><linkGroup><link type="toTypesetVersion" href="file:CEA.CEA12494.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main"><fc>BSACI</fc> guideline for the management of chronic urticaria and angioedema</title><title type="shortAuthors">R. J. Powell <i>et al</i></title></titleGroup><creators><creator affiliationRef="#cea12494-aff-0001" creatorRole="author" xml:id="cea12494-cr-0001"><personName><givenNames>R. J.</givenNames> <familyName>Powell</familyName></personName></creator><creator affiliationRef="#cea12494-aff-0002" creatorRole="author" xml:id="cea12494-cr-0002"><personName><givenNames>S. C.</givenNames> <familyName>Leech</familyName></personName></creator><creator affiliationRef="#cea12494-aff-0003" creatorRole="author" xml:id="cea12494-cr-0003"><personName><givenNames>S.</givenNames> <familyName>Till</familyName></personName></creator><creator affiliationRef="#cea12494-aff-0004" creatorRole="author" xml:id="cea12494-cr-0004"><idGroup><id type="orcid" value="http://orcid.org/0000-0002-4762-3016"></id></idGroup><personName><givenNames>P. A. J.</givenNames> <familyName>Huber</familyName></personName></creator><creator affiliationRef="#cea12494-aff-0005" creatorRole="author" xml:id="cea12494-cr-0005"><personName><givenNames>S. M.</givenNames> <familyName>Nasser</familyName></personName></creator><creator affiliationRef="#cea12494-aff-0006" corresponding="yes" creatorRole="author" xml:id="cea12494-cr-0006"><personName><givenNames>A. T.</givenNames> <familyName>Clark</familyName></personName></creator></creators><affiliationGroup><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0001"><orgDiv>Department of Clinical Immunology and Allergy</orgDiv> <orgName>Nottingham University</orgName> <address><city>Nottingham</city> <country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0002"><orgDiv>Department of Child Health</orgDiv> <orgName>Kings College Hospital</orgName> <address><city>London</city> <country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0003"><orgDiv>Division of Asthma, Allergy and Lung Biology</orgDiv> <orgName>Kings College London</orgName> <address><city>London</city> <country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0004"><orgDiv>BSACI</orgDiv> <orgName>British Society for Allergy & Clinical Immunology</orgName> <address><city>London</city> <country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0005"><orgDiv>Department of Allergy & Clinical Immunology</orgDiv> <orgName>Addenbrooke's NHS Trust</orgName> <address><city>Cambridge</city> <country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="cea12494-aff-0006"><orgDiv>Department of Allergy</orgDiv> <orgName>Addenbrookes NHS Trust</orgName> <address><city>Cambridge</city> <country>UK</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="cea12494-kwd-0001">adult</keyword><keyword xml:id="cea12494-kwd-0002">allergy</keyword><keyword xml:id="cea12494-kwd-0003">angioedema</keyword><keyword xml:id="cea12494-kwd-0004">antihistamine</keyword><keyword xml:id="cea12494-kwd-0005">anti‐IgE</keyword><keyword xml:id="cea12494-kwd-0006">auto‐antibody</keyword><keyword xml:id="cea12494-kwd-0007">autoimmune</keyword><keyword xml:id="cea12494-kwd-0008">breastfeeding</keyword><keyword xml:id="cea12494-kwd-0009"><fc>BSACI</fc></keyword><keyword xml:id="cea12494-kwd-0010">child</keyword><keyword xml:id="cea12494-kwd-0011">epidemiology</keyword><keyword xml:id="cea12494-kwd-0012">guideline</keyword><keyword xml:id="cea12494-kwd-0013">hypothyroidism</keyword><keyword xml:id="cea12494-kwd-0014">IgE</keyword><keyword xml:id="cea12494-kwd-0015">management</keyword><keyword xml:id="cea12494-kwd-0016">paraprotein</keyword><keyword xml:id="cea12494-kwd-0017">pregnancy</keyword><keyword xml:id="cea12494-kwd-0018">pregnancy</keyword><keyword xml:id="cea12494-kwd-0019">Urticaria</keyword></keywordGroup><supportingInformation><supportingInfoItem><mediaResource alt="supporting" mimeType="application/msword" href="urn-x:wiley:09547894:media:cea12494:cea12494-sup-0001-AppendixA1-A2"></mediaResource><caption><p><b>Appendix A1.</b> Patient information sheet ‐ chronic urticaria and angioedema in adults.</p><p><b>Appendix A2.</b> Patient information sheet ‐ chronic urticaria and angioedema in children.</p></caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:id="cea12494-abs-0001"><title type="main">Summary</title><p>This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (<fc>BSACI</fc>). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all <fc>BSACI</fc> members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>BSACI guideline for the management of chronic urticaria and angioedema</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>BSACI guideline for the management of chronic urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">R. J.</namePart><namePart type="family">Powell</namePart><affiliation>Department of Clinical Immunology and Allergy, Nottingham University, Nottingham, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S. C.</namePart><namePart type="family">Leech</namePart><affiliation>Department of Child Health, Kings College Hospital, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Till</namePart><affiliation>Division of Asthma, Allergy and Lung Biology, Kings College London, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P. A. J.</namePart><namePart type="family">Huber</namePart><affiliation>BSACI, British Society for Allergy & Clinical Immunology, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S. M.</namePart><namePart type="family">Nasser</namePart><affiliation>Department of Allergy & Clinical Immunology, Addenbrooke's NHS Trust, Cambridge, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A. T.</namePart><namePart type="family">Clark</namePart><affiliation>Department of Allergy, Addenbrookes NHS Trust, Cambridge, UK</affiliation><affiliation>:Dr A. T. Clark, Allergy Clinic, Cambridge University Hospitals NHS Foundation Trust, Box 40, Cambridge CB2 2QQ, UK.E‐mail:</affiliation><affiliation>E-mail: atclark@doctors.org.uk</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="announcement" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2015-03</dateIssued><dateCreated encoding="w3cdtf">2015-01-22</dateCreated><dateCaptured encoding="w3cdtf">2014-10-06</dateCaptured><dateValid encoding="w3cdtf">2015-01-09</dateValid><edition>R. J. Powell, S. C. Leech, S. Till, P. A. J. Huber, S. M. Nasser and A. T. Clark, Clinical & Experimental Allergy, 2015 (45) 547–565.</edition><copyrightDate encoding="w3cdtf">2015</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a Web‐based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.</abstract><note type="additional physical form">Appendix A1. Patient information sheet ‐ chronic urticaria and angioedema in adults. Appendix A2. Patient information sheet ‐ chronic urticaria and angioedema in children.</note><subject><genre>keywords</genre><topic>adult</topic><topic>allergy</topic><topic>angioedema</topic><topic>antihistamine</topic><topic>anti‐IgE</topic><topic>auto‐antibody</topic><topic>autoimmune</topic><topic>breastfeeding</topic><topic>BSACI</topic><topic>child</topic><topic>epidemiology</topic><topic>guideline</topic><topic>hypothyroidism</topic><topic>IgE</topic><topic>management</topic><topic>paraprotein</topic><topic>pregnancy</topic><topic>pregnancy</topic><topic>Urticaria</topic></subject><relatedItem type="host"><titleInfo><title>Clinical & Experimental Allergy</title></titleInfo><titleInfo type="abbreviated"><title>Clin Exp Allergy</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>BSACI Guideline</topic><topic>BSACI Guidelines</topic></subject><identifier type="ISSN">0954-7894</identifier><identifier type="eISSN">1365-2222</identifier><identifier type="DOI">10.1111/(ISSN)1365-2222</identifier><identifier type="PublisherID">CEA</identifier><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>547</start><end>565</end><total>19</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0001"><titleInfo><title>Epidemiology of urticaria in Spain</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Gaig</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Olona</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LD</namePart><namePart type="family">Munoz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gaig P, Olona M, Munoz LD et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004; 14:214–20.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>214</start><end>20</end></extent></part><relatedItem type="host"><titleInfo><title>J Investig Allergol Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>214</start><end>20</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0002"><titleInfo><title>Chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003; 3:363–8.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>363</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Allergy Clin Immunol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>363</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0003"><titleInfo><title>Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Baiardini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Giardini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Pasquali</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baiardini I, Giardini A, Pasquali M et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003; 58:621–3.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>621</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>621</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0004"><titleInfo><title>Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor‐patient relation</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maurer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Ortonne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zuberbier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor‐patient relation. Allergy 2009; 64:581–8.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>581</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>581</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0005"><titleInfo><title>The impact of chronic urticaria on the quality of life</title></titleInfo><name type="personal"><namePart type="given">BF</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Lawlor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Simpson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Morgan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136:197–201.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>197</start><end>201</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>197</start><end>201</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0006"><titleInfo><title>Chronic urticaria: aetiology, management and current and future treatment options</title></titleInfo><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Kozel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Sabroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004; 64:2515–36.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>2515</start><end>36</end></extent></part><relatedItem type="host"><titleInfo><title>Drugs</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>2515</start><end>36</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0007"><titleInfo><title>Classification of anti‐FcepsilonRI and anti‐IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity</title></titleInfo><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Sabroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Fiebiger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Francis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sabroe RA, Fiebiger E, Francis DM et al. Classification of anti‐FcepsilonRI and anti‐IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002; 110:492–9.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>492</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>492</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0008"><titleInfo><title>A role for C5a in augmenting IgG‐dependent histamine release from basophils in chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kikuchi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG‐dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109:114–8.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>114</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>114</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0009"><titleInfo><title>Epidemiology of urticaria: a representative cross‐sectional population survey</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zuberbier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Balke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Worm</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Edenharter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maurer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross‐sectional population survey. Clin Exp Dermatol 2010; 35:869–73.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>869</start><end>73</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>869</start><end>73</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0010"><titleInfo><title>Mechanisms of autoimmune activation of basophils in chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kikuchi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107:1056–62.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><extent unit="pages"><start>1056</start><end>62</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><extent unit="pages"><start>1056</start><end>62</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0011"><titleInfo><title>Clinical practice. Chronic urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002; 346:175–9.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>346</number></detail><extent unit="pages"><start>175</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>346</number></detail><extent unit="pages"><start>175</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0012"><titleInfo><title>Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico</title></titleInfo><name type="personal"><namePart type="given">NF</namePart><namePart type="family">Vazquez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VM</namePart><namePart type="family">meida Arvizu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HR</namePart><namePart type="family">Sanchez Nuncio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ML</namePart><namePart type="family">Villanueva Carreto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GA</namePart><namePart type="family">Guidos Fogelbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vazquez NF, meida Arvizu VM, Sanchez Nuncio HR, Villanueva Carreto ML, Guidos Fogelbach GA. Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico. Rev Alerg Mex 2004; 51:181–8.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>181</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Rev Alerg Mex</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>181</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0013"><titleInfo><title>Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti‐FcepsilonRI or anti‐IgE autoantibodies</title></titleInfo><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Sabroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PT</namePart><namePart type="family">Seed</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Francis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Barr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Black</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti‐FcepsilonRI or anti‐IgE autoantibodies. J Am Acad Dermatol 1999; 40:443–50.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>443</start><end>50</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>443</start><end>50</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0014"><titleInfo><title>Allergy is not the main trigger of urticaria in children referred to the emergency room</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Ricci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Giannetti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Belotti</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ricci G, Giannetti A, Belotti T et al. Allergy is not the main trigger of urticaria in children referred to the emergency room. J Eur Acad Dermatol Venereol 2010; 24:1347–8.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>1347</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Eur Acad Dermatol Venereol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>1347</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0015"><titleInfo><title>Psychosocial factors and chronic spontaneous urticaria: a systematic review</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ben‐Shoshan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Blinderman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Raz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ben‐Shoshan M, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy 2013; 68:131–41.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>131</start><end>41</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>131</start><end>41</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0016"><titleInfo><title>Morphologic assessment of leukocyte‐endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion</title></titleInfo><name type="personal"><namePart type="given">MG</namePart><namePart type="family">Oliver</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RD</namePart><namePart type="family">Specian</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Perry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DN</namePart><namePart type="family">Granger</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oliver MG, Specian RD, Perry MA, Granger DN. Morphologic assessment of leukocyte‐endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation 1991; 15:331–46.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>331</start><end>46</end></extent></part><relatedItem type="host"><titleInfo><title>Inflammation</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>331</start><end>46</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0017"><titleInfo><title>Integration of inflammatory signals by rolling neutrophils</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Ley</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002; 186:8–18.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>186</number></detail><extent unit="pages"><start>8</start><end>18</end></extent></part><relatedItem type="host"><titleInfo><title>Immunol Rev</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>186</number></detail><extent unit="pages"><start>8</start><end>18</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0018"><titleInfo><title>Autoantibodies to the high‐affinity IgE receptor in children with chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Du Toit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Prescott</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Lawrence</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Du Toit G, Prescott R, Lawrence P et al. Autoantibodies to the high‐affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol 2006; 96:341–4.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>341</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>341</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0019"><titleInfo><title>High prevalence of autoimmune urticaria in children with chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Brunetti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Francavilla</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VL</namePart><namePart type="family">Miniello</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brunetti L, Francavilla R, Miniello VL et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004; 114:922–7.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>922</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>922</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0020"><titleInfo><title>Prevalence and functional role of anti‐IgE autoantibodies in urticarial syndromes</title></titleInfo><name type="personal"><namePart type="given">BL</namePart><namePart type="family">Gruber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ML</namePart><namePart type="family">Baeza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Marchese</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Agnello</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP. Prevalence and functional role of anti‐IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988; 90:213–7.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>213</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>J Invest Dermatol</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>213</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0021"><titleInfo><title>EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria</title></titleInfo><name type="personal"><namePart type="given">GN</namePart><namePart type="family">Konstantinou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Asero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ferrer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Konstantinou GN, Asero R, Ferrer M et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013; 68:27–36.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>27</start><end>36</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>27</start><end>36</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0022"><titleInfo><title>Mast cells are critically involved in serum‐mediated vascular leakage in chronic urticaria beyond high‐affinity IgE receptor stimulation</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Bossi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Frossi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Radillo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bossi F, Frossi B, Radillo O et al. Mast cells are critically involved in serum‐mediated vascular leakage in chronic urticaria beyond high‐affinity IgE receptor stimulation. Allergy 2011; 66:1538–45.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>1538</start><end>45</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>1538</start><end>45</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0023"><titleInfo><title>Chronic urticaria: novel clinical and serological aspects</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Asero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Tedeschi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Lorini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Salimbeni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zanoletti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Miadonna</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001; 31:1105–10.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1105</start><end>10</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1105</start><end>10</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0024"><titleInfo><title>Complement dependence of histamine release in chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ferrer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Nakazawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104:169–72.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>169</start><end>72</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>169</start><end>72</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0025"><titleInfo><title>Urticaria and hepatitis C</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Reichel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TM</namePart><namePart type="family">Mauro</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990; 336:822–3.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>336</number></detail><extent unit="pages"><start>822</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>336</number></detail><extent unit="pages"><start>822</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0026"><titleInfo><title>Hepatitis C virus infection in patients with urticaria</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Kanazawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yaoita</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Tsuda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Okamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996; 35:195–8.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>195</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>195</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0027"><titleInfo><title>Hepatitis C and urticaria: cause and effect?</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Siddique</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BN</namePart><namePart type="family">Pereira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Hasan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Siddique N, Pereira BN, Hasan AS. Hepatitis C and urticaria: cause and effect? Allergy 2004; 59:668.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>668</start></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>668</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0028"><titleInfo><title>Testing for hepatitis B virus in patients with chronic urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">GA</namePart><namePart type="family">Vaida</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Goldman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KJ</namePart><namePart type="family">Bloch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vaida GA, Goldman MA, Bloch KJ. Testing for hepatitis B virus in patients with chronic urticaria and angioedema. J Allergy Clin Immunol 1983; 72:193–8.</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>193</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>193</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0029"><titleInfo><title>Consensus meeting on the definition of physical urticarias and urticarial vasculitis</title></titleInfo><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Black</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Lawlor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Black AK, Lawlor F, Greaves MW. Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 1996; 21:424–6.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>424</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Dermatol</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>424</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0030"><titleInfo><title>The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose‐alpha‐1,3‐galactose</title></titleInfo><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Commins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HR</namePart><namePart type="family">James</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Kelly</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Commins SP, James HR, Kelly LA et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose‐alpha‐1,3‐galactose. J Allergy Clin Immunol 2011; 127:1286–93.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>127</number></detail><extent unit="pages"><start>1286</start><end>93</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>127</number></detail><extent unit="pages"><start>1286</start><end>93</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0031"><titleInfo><title>Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ozkan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SB</namePart><namePart type="family">Oflaz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Kocaman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ozkan M, Oflaz SB, Kocaman N et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007; 99:29–33.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>29</start><end>33</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>29</start><end>33</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0032"><titleInfo><title>Stressful life events and skin diseases: disentangling evidence from myth</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Picardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Abeni</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70:118–36.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>118</start><end>36</end></extent></part><relatedItem type="host"><titleInfo><title>Psychother Psychosom</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>118</start><end>36</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0033"><titleInfo><title>High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Staubach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dechene</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Metz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Staubach P, Dechene M, Metz M et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol 2011; 91:557–61.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>557</start><end>61</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>557</start><end>61</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0034"><titleInfo><title>Chronic urticaria is usually associated with fibromyalgia syndrome</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Torresani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Bellafiore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PG</namePart><namePart type="family">De</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Torresani C, Bellafiore S, De PG. Chronic urticaria is usually associated with fibromyalgia syndrome. Acta Derm Venereol 2009; 89:389–92.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>89</number></detail><extent unit="pages"><start>389</start><end>92</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>89</number></detail><extent unit="pages"><start>389</start><end>92</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0035"><titleInfo><title>Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Staubach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Eckhardt‐Henn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dechene</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Staubach P, Eckhardt‐Henn A, Dechene M et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154:294–8.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>154</number></detail><extent unit="pages"><start>294</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>154</number></detail><extent unit="pages"><start>294</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0036"><titleInfo><title>Stress, psychiatric co‐morbidity and coping in patients with chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Chung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Symons</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Gilliam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ER</namePart><namePart type="family">Kaminski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chung MC, Symons C, Gilliam J, Kaminski ER. Stress, psychiatric co‐morbidity and coping in patients with chronic idiopathic urticaria. Psychol Health 2010; 25:477–90.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>477</start><end>90</end></extent></part><relatedItem type="host"><titleInfo><title>Psychol Health</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>477</start><end>90</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0037"><titleInfo><title>Chronic urticaria: pathogenesis and treatment</title></titleInfo><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114:465–74.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>465</start><end>74</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>465</start><end>74</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0038"><titleInfo><title>Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Campanati</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gesuita</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Giannoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Campanati A, Gesuita R, Giannoni M et al. Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis. Acta Derm Venereol 2013; 93:161–4.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>161</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>161</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0039"><titleInfo><title>The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">DG</namePart><namePart type="family">Federman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Kirsner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Moriarty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Concato</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49:861–4.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>861</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>861</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0040"><titleInfo><title>Drug‐induced angioedema without urticaria</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Agostoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cicardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Agostoni A, Cicardi M. Drug‐induced angioedema without urticaria. Drug Saf 2001; 24:599–606.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>599</start><end>606</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Saf</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>599</start><end>606</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0041"><titleInfo><title>Lee A. Adverse drug reactions. 2nd edn. London UK: Pharmaceutical Press, 2006.</title></titleInfo><note type="citation/reference">Lee A. Adverse drug reactions. 2nd edn. London UK: Pharmaceutical Press, 2006.</note><name type="personal"><namePart type="given">A</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Pharmaceutical Press</publisher><place><placeTerm type="text">London UK</placeTerm></place></originInfo><part><date>2006</date></part></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0042"><titleInfo><title>Incidence and characteristics of angioedema associated with enalapril</title></titleInfo><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Kostis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HJ</namePart><namePart type="family">Kim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Rusnak</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005; 165:1637–42.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1637</start><end>42</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1637</start><end>42</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0043"><titleInfo><title>ACE inhibitor‐induced angioedema. Incidence, prevention and management</title></titleInfo><name type="personal"><namePart type="given">W</namePart><namePart type="family">Vleeming</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JG</namePart><namePart type="family">van Amsterdam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BH</namePart><namePart type="family">Stricker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">de Wildt</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor‐induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18:171–88.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>171</start><end>88</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Saf</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>171</start><end>88</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0044"><titleInfo><title>Late onset angiotensin‐converting enzyme induced angioedema: case report and review of the literature</title></titleInfo><name type="personal"><namePart type="given">X</namePart><namePart type="family">Guo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Dick</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guo X, Dick L. Late onset angiotensin‐converting enzyme induced angioedema: case report and review of the literature. J Okla State Med Assoc 1999; 92:71–3.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>71</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>J Okla State Med Assoc</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>71</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0045"><titleInfo><title>Angioedema associated with angiotensin‐converting enzyme inhibitor use: outcome after switching to a different treatment</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cicardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LC</namePart><namePart type="family">Zingale</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Bergamaschini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Agostoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin‐converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004; 164:910–3.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>164</number></detail><extent unit="pages"><start>910</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>164</number></detail><extent unit="pages"><start>910</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0046"><titleInfo><title>Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease</title></titleInfo><name type="personal"><namePart type="given">DE</namePart><namePart type="family">Dean</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Schultz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RH</namePart><namePart type="family">Powers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001; 46:1239–43.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1239</start><end>43</end></extent></part><relatedItem type="host"><titleInfo><title>J Forensic Sci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1239</start><end>43</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0047"><titleInfo><title>Late angio‐oedema in patients taking angiotensin‐converting‐enzyme inhibitors</title></titleInfo><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Pavletic</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pavletic AJ. Late angio‐oedema in patients taking angiotensin‐converting‐enzyme inhibitors. Lancet 2002; 360:493–4.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>360</number></detail><extent unit="pages"><start>493</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>360</number></detail><extent unit="pages"><start>493</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0048"><titleInfo><title>Hereditary and other orphan angioedemas: a new prophylactic option at last?</title></titleInfo><name type="personal"><namePart type="given">HJ</namePart><namePart type="family">Longhurst</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Longhurst HJ. Hereditary and other orphan angioedemas: a new prophylactic option at last? Clin Exp Allergy 2013; 43:380–2.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>380</start><end>2</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>380</start><end>2</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0049"><titleInfo><title>Benefits of progestin contraception in non‐allergic angioedema</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Saule</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Boccon‐Gibod</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Fain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Saule C, Boccon‐Gibod I, Fain O et al. Benefits of progestin contraception in non‐allergic angioedema. Clin Exp Allergy 2013; 43:475–82.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>475</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>475</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0050"><titleInfo><title>HAE update: special considerations in the female patient with hereditary angioedema</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Geng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Riedl</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Geng B, Riedl MA. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc 2013; 34:13–8.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>13</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Proc</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>13</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0051"><titleInfo><title>The characteristics of urticaria in 390 patients</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Humphreys</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Hunter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. Br J Dermatol 1998; 138:635–8.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>635</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>635</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0052"><titleInfo><title>Urticaria: then and now</title></titleInfo><name type="personal"><namePart type="given">RH</namePart><namePart type="family">Champion</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Champion RH. Urticaria: then and now. Br J Dermatol 1988; 119:427–36.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>427</start><end>36</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>427</start><end>36</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0053"><titleInfo><title>Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Toubi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kessel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Avshovich</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Toubi E, Kessel A, Avshovich N et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004; 59:869–73.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>869</start><end>73</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>869</start><end>73</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0054"><titleInfo><title>The effectiveness of a history‐based diagnostic approach in chronic urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Kozel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Mekkes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PM</namePart><namePart type="family">Bossuyt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JD</namePart><namePart type="family">Bos</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. The effectiveness of a history‐based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134:1575–80.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>134</number></detail><extent unit="pages"><start>1575</start><end>80</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>134</number></detail><extent unit="pages"><start>1575</start><end>80</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0055"><titleInfo><title>Unlocking the resistance to wheat lipid transfer protein</title></titleInfo><name type="personal"><namePart type="given">PM</namePart><namePart type="family">Gamboa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Gonzalez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Pereira</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gamboa PM, Gonzalez C, Pereira C et al. Unlocking the resistance to wheat lipid transfer protein. J Allergy Clin Immunol 2013; 132:1257–8.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>1257</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>1257</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0056"><titleInfo><title>Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas</title></titleInfo><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Ventura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Napolitano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Menga</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cecere</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Asero</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ventura MT, Napolitano S, Menga R, Cecere R, Asero R. Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas. Int Arch Allergy Immunol 2013; 160:297–300.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>160</number></detail><extent unit="pages"><start>297</start><end>300</end></extent></part><relatedItem type="host"><titleInfo><title>Int Arch Allergy Immunol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>160</number></detail><extent unit="pages"><start>297</start><end>300</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0057"><titleInfo><title>Chronic urticaria is associated with a differential helminth‐arthropod‐related atopy phenotype</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Daschner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rodero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FC</namePart><namePart type="family">De</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Valls</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Cuellar</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Daschner A, Rodero M, De FC, Valls A, Cuellar C. Chronic urticaria is associated with a differential helminth‐arthropod‐related atopy phenotype. J Dermatol 2010; 37:780–5.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>780</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>780</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0058"><titleInfo><title>Anisakis simplex sensitization‐associated urticaria: short‐lived immediate type or prolonged acute urticaria</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Daschner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FC</namePart><namePart type="family">De</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Valls</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Vega</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Daschner A, De FC, Valls A, Vega F. Anisakis simplex sensitization‐associated urticaria: short‐lived immediate type or prolonged acute urticaria. Arch Dermatol Res 2010; 302:625–9.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>302</number></detail><extent unit="pages"><start>625</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol Res</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>302</number></detail><extent unit="pages"><start>625</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0059"><titleInfo><title>Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kiyici</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OO</namePart><namePart type="family">Gul</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EB</namePart><namePart type="family">Baskan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kiyici S, Gul OO, Baskan EB et al. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol 2010; 35:603–7.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>603</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>603</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0060"><titleInfo><title>Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Leznoff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GL</namePart><namePart type="family">Sussman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84:66–71.</note><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>66</start><end>71</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>66</start><end>71</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0061"><titleInfo><title>Association of chronic urticaria and angioedema with thyroid autoimmunity</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Leznoff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RG</namePart><namePart type="family">Josse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Denburg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dolovich</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983; 119:636–40.</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>636</start><end>40</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>636</start><end>40</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0062"><titleInfo><title>Resolution of chronic urticaria in patients with thyroid autoimmunity</title></titleInfo><name type="personal"><namePart type="given">JS</namePart><namePart type="family">Rumbyrt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Katz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AL</namePart><namePart type="family">Schocket</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96:901–5.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>901</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>901</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0063"><titleInfo><title>C1 inhibitor deficiency: consensus document</title></titleInfo><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Gompels</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Lock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Abinun</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379–94.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>379</start><end>94</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Immunol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>379</start><end>94</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0064"><titleInfo><title>Oral iron therapy and chronic idiopathic urticaria: sideropenic urticaria?</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Guarneri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Guarneri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Cannavo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guarneri F, Guarneri C, Cannavo SP. Oral iron therapy and chronic idiopathic urticaria: sideropenic urticaria? Dermatol Ther 2014; 27:223–6.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>223</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Dermatol Ther</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>223</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0065"><titleInfo><title>Low B12 levels in chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Mete</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Gulbahar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Aydin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AZ</namePart><namePart type="family">Sin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kokuludag</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Sebik</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mete N, Gulbahar O, Aydin A, Sin AZ, Kokuludag A, Sebik F. Low B12 levels in chronic idiopathic urticaria. J Investig Allergol Clin Immunol 2004; 14:292–9.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>292</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>J Investig Allergol Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>292</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0066"><titleInfo><title>Schnitzler's syndrome: diagnosis, treatment, and follow‐up</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Simon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Asli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Braun‐Falco</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simon A, Asli B, Braun‐Falco M et al. Schnitzler's syndrome: diagnosis, treatment, and follow‐up. Allergy 2013; 68:562–8.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>562</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>562</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0067"><titleInfo><title>The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Sabroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Grattan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Francis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Barr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BA</namePart><namePart type="family">Kobza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza BA, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140:446–52.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>140</number></detail><extent unit="pages"><start>446</start><end>52</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>140</number></detail><extent unit="pages"><start>446</start><end>52</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0068"><titleInfo><title>Independent evaluation of a commercial test for “autoimmune” urticaria in normal and chronic urticaria subjects</title></titleInfo><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Eckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RG</namePart><namePart type="family">Hamilton</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SS</namePart><namePart type="family">Saini</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Eckman JA, Hamilton RG, Saini SS. Independent evaluation of a commercial test for “autoimmune” urticaria in normal and chronic urticaria subjects. J Invest Dermatol 2009; 129:1584–6.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>129</number></detail><extent unit="pages"><start>1584</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>J Invest Dermatol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>129</number></detail><extent unit="pages"><start>1584</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0069"><titleInfo><title>How to assess disease activity in patients with chronic urticaria?</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Mlynek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Zalewska‐Janowska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Martus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Staubach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zuberbier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maurer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mlynek A, Zalewska‐Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63:777–80.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>777</start><end>80</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>777</start><end>80</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0070"><titleInfo><title>The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Jariwala</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Moday</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ML</namePart><namePart type="family">de Asis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jariwala SP, Moday H, de Asis ML et al. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Ann Allergy Asthma Immunol 2009; 102:475–82.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>475</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>475</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0071"><titleInfo><title>Management and diagnostic guidelines for urticaria and angio‐oedema</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Grattan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Powell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Humphreys</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio‐oedema. Br J Dermatol 2001; 144:708–14.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>144</number></detail><extent unit="pages"><start>708</start><end>14</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>144</number></detail><extent unit="pages"><start>708</start><end>14</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0072"><titleInfo><title>The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult‐to‐treat urticaria</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Staevska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TA</namePart><namePart type="family">Popov</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kralimarkova</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Staevska M, Popov TA, Kralimarkova T et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult‐to‐treat urticaria. J Allergy Clin Immunol 2010; 125:676–82.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>676</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>676</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0073"><titleInfo><title>How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life</title></titleInfo><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Grob</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Auquier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Dreyfus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Ortonne</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grob JJ, Auquier P, Dreyfus I, Ortonne JP. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009; 64:605–12.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>605</start><end>12</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>605</start><end>12</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0074"><titleInfo><title>The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zuberbier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Aberer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Asero</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zuberbier T, Aberer W, Asero R et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69:868–87.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>69</number></detail><extent unit="pages"><start>868</start><end>87</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>69</number></detail><extent unit="pages"><start>868</start><end>87</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0075"><titleInfo><title>Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Baiardini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Braido</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Bindslev‐Jensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baiardini I, Braido F, Bindslev‐Jensen C et al. Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011; 66:840–4.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>840</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>840</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0076"><titleInfo><title>Night‐time sedating H1‐antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Staevska</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Gugutkova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Lazarova</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Staevska M, Gugutkova M, Lazarova C et al. Night‐time sedating H1‐antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol 2014; 171:148–54.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>171</number></detail><extent unit="pages"><start>148</start><end>54</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>171</number></detail><extent unit="pages"><start>148</start><end>54</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0077"><titleInfo><title>Advances in H1‐antihistamines</title></titleInfo><name type="personal"><namePart type="given">FE</namePart><namePart type="family">Simons</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simons FE. Advances in H1‐antihistamines. N Engl J Med 2004; 351:2203–17.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>351</number></detail><extent unit="pages"><start>2203</start><end>17</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>351</number></detail><extent unit="pages"><start>2203</start><end>17</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0078"><titleInfo><title>Appraisal of the validity of histamine‐induced wheal and flare to predict the clinical efficacy of antihistamines</title></titleInfo><name type="personal"><namePart type="given">EW</namePart><namePart type="family">Monroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AF</namePart><namePart type="family">Daly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RF</namePart><namePart type="family">Shalhoub</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Monroe EW, Daly AF, Shalhoub RF. Appraisal of the validity of histamine‐induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol 1997; 99:S798–806.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>S798</start><end>806</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>S798</start><end>806</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0079"><titleInfo><title>Inhibition of the histamine‐induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Devillier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Bousquet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Devillier P, Bousquet J. Inhibition of the histamine‐induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy? Clin Exp Allergy 2007; 37:400–14.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>400</start><end>14</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>400</start><end>14</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0080"><titleInfo><title>H(1)‐antihistamines and urticaria: how can we predict the best drug for our patient?</title></titleInfo><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Church</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maurer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Church MK, Maurer M. H(1)‐antihistamines and urticaria: how can we predict the best drug for our patient? Clin Exp Allergy 2012; 42:1423–9.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1423</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1423</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0081"><titleInfo><title>The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results</title></titleInfo><name type="personal"><namePart type="given">SE</namePart><namePart type="family">Bagenstose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Levin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Bernstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113:134–40.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>113</number></detail><extent unit="pages"><start>134</start><end>40</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>113</number></detail><extent unit="pages"><start>134</start><end>40</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0082"><titleInfo><title>Efficacy of leukotriene receptor antagonist in chronic urticaria. A double‐blind, placebo‐controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid</title></titleInfo><name type="personal"><namePart type="given">ML</namePart><namePart type="family">Pacor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Di Lorenzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Corrocher</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double‐blind, placebo‐controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001; 31:1607–14.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1607</start><end>14</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1607</start><end>14</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0083"><titleInfo><title>Pretreatment with montelukast blocks NSAID‐induced urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Perez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Sanchez‐Borges</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Capriles</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Perez C, Sanchez‐Borges M, Capriles E. Pretreatment with montelukast blocks NSAID‐induced urticaria and angioedema. J Allergy Clin Immunol 2001; 108:1060–1.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1060</start><end>1</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1060</start><end>1</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0084"><titleInfo><title>Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Nettis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Pannofino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Cavallo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ferrannini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Tursi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol 2003; 112:212–3.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>212</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>212</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0085"><titleInfo><title>Montelukast‐induced generalized urticaria</title></titleInfo><name type="personal"><namePart type="given">PL</namePart><namePart type="family">Minciullo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Saija</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Bonanno</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Ferlazzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Gangemi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Minciullo PL, Saija A, Bonanno D, Ferlazzo E, Gangemi S. Montelukast‐induced generalized urticaria. Ann Pharmacother 2004; 38:999–1001.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>999</start><end>1001</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>999</start><end>1001</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0086"><titleInfo><title>Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Maurer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Rosen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HJ</namePart><namePart type="family">Hsieh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maurer M, Rosen K, Hsieh HJ et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013; 368:924–35.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>368</number></detail><extent unit="pages"><start>924</start><end>35</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>368</number></detail><extent unit="pages"><start>924</start><end>35</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0087"><titleInfo><title>Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria</title></titleInfo><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Grattan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BF</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Francis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grattan CE, O'Donnell BF, Francis DM et al. Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol 2000; 143:365–72.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>143</number></detail><extent unit="pages"><start>365</start><end>72</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>143</number></detail><extent unit="pages"><start>365</start><end>72</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0088"><titleInfo><title>Treatment of autoimmune urticaria with low‐dose cyclosporin A: a one‐year follow‐up</title></titleInfo><name type="personal"><namePart type="given">CD</namePart><namePart type="family">Boubouka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Charissi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Kouimintzis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Kalogeromitros</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PG</namePart><namePart type="family">Stavropoulos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Katsarou</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Boubouka CD, Charissi C, Kouimintzis D, Kalogeromitros D, Stavropoulos PG, Katsarou A. Treatment of autoimmune urticaria with low‐dose cyclosporin A: a one‐year follow‐up. Acta Derm Venereol 2011; 91:50–4.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>50</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>50</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0089"><titleInfo><title>Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Shahar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Bergman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Guttman‐Yassky</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Pollack</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shahar E, Bergman R, Guttman‐Yassky E, Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006; 45:1224–7.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>1224</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>1224</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0090"><titleInfo><title>Histamine H2‐receptor antagonists for urticaria</title></titleInfo><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Fedorowicz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">van Zuuren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Hu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2‐receptor antagonists for urticaria. Cochrane Database Syst Rev 2012; 3:CD008596.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>CD008596</start></extent></part><relatedItem type="host"><titleInfo><title>Cochrane Database Syst Rev</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>CD008596</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0091"><titleInfo><title>Effect of the H2‐antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1‐antagonists hydroxyzine and cetirizine in patients with chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">FE</namePart><namePart type="family">Simons</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GL</namePart><namePart type="family">Sussman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KJ</namePart><namePart type="family">Simons</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simons FE, Sussman GL, Simons KJ. Effect of the H2‐antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1‐antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995; 95:685–93.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>685</start><end>93</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>685</start><end>93</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0092"><titleInfo><title>Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double‐blind study in 45 patients</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Paul</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RH</namePart><namePart type="family">Bodeker</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Paul E, Bodeker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double‐blind study in 45 patients. Eur J Clin Pharmacol 1986; 31:277–80.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>277</start><end>80</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>277</start><end>80</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0093"><titleInfo><title>Icatibant, a new bradykinin‐receptor antagonist, in hereditary angioedema</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cicardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Banerji</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Bracho</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cicardi M, Banerji A, Bracho F et al. Icatibant, a new bradykinin‐receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363:532–41.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>363</number></detail><extent unit="pages"><start>532</start><end>41</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>363</number></detail><extent unit="pages"><start>532</start><end>41</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0094"><titleInfo><title>2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Bowen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cicardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Farkas</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bowen T, Cicardi M, Farkas H et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6:24.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>24</start></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Clin Immunol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>24</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0095"><titleInfo><title>Therapeutic efficacy of icatibant in angioedema induced by angiotensin‐converting enzyme inhibitors: a case series</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Greve</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Stelter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bas M, Greve J, Stelter K et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin‐converting enzyme inhibitors: a case series. Ann Emerg Med 2010; 56:278–82.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>278</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Emerg Med</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>278</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0096"><titleInfo><title>Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Rajan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Simon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JV</namePart><namePart type="family">Bosso</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rajan JP, Simon RA, Bosso JV. Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. J Allergy Clin Immunol Pract 2014; 2:168–71.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>168</start><end>71</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol Pract</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>168</start><end>71</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0097"><titleInfo><title>Suspected tartrazine‐induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Nettis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Colanardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ferrannini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Tursi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nettis E, Colanardi MC, Ferrannini A, Tursi A. Suspected tartrazine‐induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge. Clin Exp Allergy 2003; 33:1725–9.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>1725</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>1725</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0098"><titleInfo><title>Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Rorie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WS</namePart><namePart type="family">Goldner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Lyden</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Poole</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rorie A, Goldner WS, Lyden E, Poole JA. Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study. Ann Allergy Asthma Immunol 2014; 112:376–82.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>376</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>376</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0099"><titleInfo><title>The RCPCH care pathway for children with urticaria, angio‐oedema or mastocytosis: an evidence and consensus based national approach</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Leech</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Grattan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Lloyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leech S, Grattan C, Lloyd K et al. The RCPCH care pathway for children with urticaria, angio‐oedema or mastocytosis: an evidence and consensus based national approach. Arch Dis Child 2011; 96(Suppl. 2):i34–7.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 2</number></detail><extent unit="pages"><start>i34</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dis Child</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 2</number></detail><extent unit="pages"><start>i34</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0100"><titleInfo><title>Chronic urticaria in childhood</title></titleInfo><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Greaves MW. Chronic urticaria in childhood. Allergy 2000; 55:309–20.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>309</start><end>20</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>309</start><end>20</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0101"><titleInfo><title>Chronic urticaria: association with thyroid autoimmunity</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Levy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Segal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Weintrob</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YL</namePart><namePart type="family">Danon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch Dis Child 2003; 88:517–9.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>517</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dis Child</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>517</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0102"><titleInfo><title>Stiehm ER. Immunologic disorders in infants and children. 4th edn. Philadelphia: W.B. Saunders, 1996.</title></titleInfo><note type="citation/reference">Stiehm ER. Immunologic disorders in infants and children. 4th edn. Philadelphia: W.B. Saunders, 1996.</note><name type="personal"><namePart type="given">ER</namePart><namePart type="family">Stiehm</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>W.B. Saunders</publisher><place><placeTerm type="text">Philadelphia</placeTerm></place></originInfo><part><date>1996</date></part></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0103"><titleInfo><title>How not to miss autoinflammatory diseases masquerading as urticaria</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Krause</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Grattan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Bindslev‐Jensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Krause K, Grattan CE, Bindslev‐Jensen C et al. How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 2012; 67:1465–74.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>1465</start><end>74</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>1465</start><end>74</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0104"><titleInfo><title>Prevalence of silent coeliac disease in atopics</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Zauli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Grassi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Granito</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zauli D, Grassi A, Granito A et al. Prevalence of silent coeliac disease in atopics. Dig Liver Dis 2000; 32:775–9.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>775</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Dig Liver Dis</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>775</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0105"><titleInfo><title>Idiopathic chronic urticaria and celiac disease</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Gabrielli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Candelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Cremonini</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gabrielli M, Candelli M, Cremonini F et al. Idiopathic chronic urticaria and celiac disease. Dig Dis Sci 2005; 50:1702–4.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1702</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Dig Dis Sci</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1702</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0106"><titleInfo><title>Chronic urticaria and associated coeliac disease in children: a case‐control study</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Caminiti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Passalacqua</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Magazzu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Caminiti L, Passalacqua G, Magazzu G et al. Chronic urticaria and associated coeliac disease in children: a case‐control study. Pediatr Allergy Immunol 2005; 16:428–32.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>428</start><end>32</end></extent></part><relatedItem type="host"><titleInfo><title>Pediatr Allergy Immunol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>428</start><end>32</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0107"><titleInfo><title>The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters</title></titleInfo><genre>journal-article</genre><note type="citation/reference">The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000; 85:521–44.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>521</start><end>44</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>521</start><end>44</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0108"><titleInfo><title>Pediatric hereditary angioedema due to C1‐inhibitor deficiency</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Farkas</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Farkas H. Pediatric hereditary angioedema due to C1‐inhibitor deficiency. Allergy Asthma Clin Immunol 2010; 6:18.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>18</start></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Clin Immunol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>18</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0109"><titleInfo><title>Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Du‐Thanh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Raison‐Peyron</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Drouet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Guillot</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Du‐Thanh A, Raison‐Peyron N, Drouet C, Guillot B. Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 2010; 65:793–5.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>793</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>793</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0110"><titleInfo><title>Real‐life experiences with omalizumab for the treatment of chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Sussman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hebert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Barron</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sussman G, Hebert J, Barron C et al. Real‐life experiences with omalizumab for the treatment of chronic urticaria. Ann Allergy Asthma Immunol 2014; 112:170–4.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>170</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>170</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0111"><titleInfo><title>Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Ledford</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ashby</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kaplan A, Ledford D, Ashby M et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 2013; 132:101–9.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>101</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>101</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0112"><titleInfo><title>First‐trimester drug use and congenital disorders</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Aselton</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Jick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Milunsky</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Hunter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Stergachis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A. First‐trimester drug use and congenital disorders. Obstet Gynecol 1985; 65:451–5.</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>451</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>451</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0113"><titleInfo><title>First‐trimester drug use and congenital disorders</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Jick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LB</namePart><namePart type="family">Holmes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Hunter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Madsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Stergachis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First‐trimester drug use and congenital disorders. JAMA 1981; 246:343–6.</note><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>246</number></detail><extent unit="pages"><start>343</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>246</number></detail><extent unit="pages"><start>343</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0114"><titleInfo><title>Use of antihistamine drugs in early pregnancy and delivery outcome</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Kallen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002; 11:146–52.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>146</start><end>52</end></extent></part><relatedItem type="host"><titleInfo><title>J Matern Fetal Neonatal Med</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>146</start><end>52</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0115"><titleInfo><title>Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study</title></titleInfo><name type="personal"><namePart type="given">O</namePart><namePart type="family">Diav‐Citrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Shechtman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Aharonovich</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Diav‐Citrin O, Shechtman S, Aharonovich A et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol 2003; 111:1239–43.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1239</start><end>43</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1239</start><end>43</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0116"><titleInfo><title>Prospective controlled study of hydroxyzine and cetirizine in pregnancy</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Einarson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Bailey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Jung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Spizzirri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Baillie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Koren</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Einarson A, Bailey B, Jung G, Spizzirri D, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997; 78:183–6.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>183</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>183</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0117"><titleInfo><title>Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, 1977.</title></titleInfo><note type="citation/reference">Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, 1977.</note><name type="personal"><namePart type="given">OP</namePart><namePart type="family">Heinonen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Slone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Shapiro</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Publishing Sciences Group</publisher><place><placeTerm type="text">Littleton, MA</placeTerm></place></originInfo><part><date>1977</date></part></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0118"><titleInfo><title>Excretion of loratadine in human breast milk</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hilbert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Radwanski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MB</namePart><namePart type="family">Affrime</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Perentesis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Symchowicz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Zampaglione</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988; 28:234–9.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>234</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>234</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0119"><titleInfo><title>Briggs GB, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th Edn. Philadelphia: Lippincott Williams & Wilkins, 2001.</title></titleInfo><note type="citation/reference">Briggs GB, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th Edn. Philadelphia: Lippincott Williams & Wilkins, 2001.</note><name type="personal"><namePart type="given">GB</namePart><namePart type="family">Briggs</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RK</namePart><namePart type="family">Freeman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SJ</namePart><namePart type="family">Yaffe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Lippincott Williams & Wilkins</publisher><place><placeTerm type="text">Philadelphia</placeTerm></place></originInfo><part><date>2001</date></part></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0120"><titleInfo><title>Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Zuberbier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Oanta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Bogacka</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zuberbier T, Oanta A, Bogacka E et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study. Allergy 2010; 65:516–28.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>516</start><end>28</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>516</start><end>28</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0121"><titleInfo><title>Intravenous immunoglobulin in autoimmune chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">BF</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Barr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Black</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">O'Donnell BF, Barr RM, Black AK et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138:101–6.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>101</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>101</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0122"><titleInfo><title>Randomized placebo‐controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Di Lorenzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ML</namePart><namePart type="family">Pacor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Mansueto</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Di Lorenzo G, Pacor ML, Mansueto P et al. Randomized placebo‐controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004; 114:619–25.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>619</start><end>25</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>619</start><end>25</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0123"><titleInfo><title>A double‐blind, placebo‐controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">AF</namePart><namePart type="family">Finn Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Fretwell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Qu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Long</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double‐blind, placebo‐controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999; 104:1071–8.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>1071</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>1071</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0124"><titleInfo><title>The acute and sub‐chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Hindmarch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Johnson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Meadows</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kirkpatrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Shamsi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hindmarch I, Johnson S, Meadows R, Kirkpatrick T, Shamsi Z. The acute and sub‐chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Curr Med Res Opin 2001; 17:241–55.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>241</start><end>55</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Med Res Opin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>241</start><end>55</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0125"><titleInfo><title>Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">EW</namePart><namePart type="family">Monroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RW</namePart><namePart type="family">Fox</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AW</namePart><namePart type="family">Green</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Monroe EW, Fox RW, Green AW et al. Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol 1988; 19:138–9.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>138</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>138</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0126"><titleInfo><title>Efficacy and safety of mizolastine 10 mg in a placebo‐controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Dubertret</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Murrieta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Tonet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dubertret L, Murrieta AM, Tonet J. Efficacy and safety of mizolastine 10 mg in a placebo‐controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 1999; 12:16–24.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>16</start><end>24</end></extent></part><relatedItem type="host"><titleInfo><title>J Eur Acad Dermatol Venereol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>16</start><end>24</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0127"><titleInfo><title>Rupatadine in allergic rhinitis and chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Mullol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Bousquet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Bachert</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mullol J, Bousquet J, Bachert C et al. Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008; 63(Suppl. 87):5–28.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 87</number></detail><extent unit="pages"><start>5</start><end>28</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 87</number></detail><extent unit="pages"><start>5</start><end>28</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0128"><titleInfo><title>Zafirlukast has no beneficial effects in the treatment of chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Reimers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Pichler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Helbling</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WJ</namePart><namePart type="family">Pichler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Yawalkar</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002; 32:1763–8.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>1763</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>1763</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0129"><titleInfo><title>Idiopathic nonhistaminergic angioedema</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Cicardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Bergamaschini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LC</namePart><namePart type="family">Zingale</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Gioffre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Agostoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999; 106:650–4.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>106</number></detail><extent unit="pages"><start>650</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Med</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>106</number></detail><extent unit="pages"><start>650</start><end>4</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0130"><titleInfo><title>Tranexamic acid (Cyklokapron) in chronic urticaria: a double‐blind study</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Laurberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Laurberg G. Tranexamic acid (Cyklokapron) in chronic urticaria: a double‐blind study. Acta Derm Venereol 1977; 57:369–70.</note><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>369</start><end>70</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>369</start><end>70</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0131"><titleInfo><title>The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients</title></titleInfo><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Zimmerman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EM</namePart><namePart type="family">Berger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SB</namePart><namePart type="family">Elmariah</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NA</namePart><namePart type="family">Soter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zimmerman AB, Berger EM, Elmariah SB, Soter NA. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol 2012; 66:767–70.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>767</start><end>70</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>767</start><end>70</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0132"><titleInfo><title>Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open‐label prospective study</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kessel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Bamberger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Toubi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open‐label prospective study. J Am Acad Dermatol 2005; 52:145–8.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>145</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>145</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0133"><titleInfo><title>Clinical guidelines: developing guidelines</title></titleInfo><name type="personal"><namePart type="given">PG</namePart><namePart type="family">Shekelle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Woolf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Eccles</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Grimshaw</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999; 318:593–6.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>318</number></detail><extent unit="pages"><start>593</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>318</number></detail><extent unit="pages"><start>593</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0134"><titleInfo><title>British guideline on the management of asthma</title></titleInfo><genre>journal-article</genre><note type="citation/reference">British guideline on the management of asthma. Thorax 2003; 58(Suppl. 1):i1–94.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>i1</start><end>94</end></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>i1</start><end>94</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0135"><titleInfo><title>Sustained dapsone‐induced remission of hypocomplementemic urticarial vasculitis–a case report</title></titleInfo><name type="personal"><namePart type="given">AR</namePart><namePart type="family">Eiser</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Singh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Shanies</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Eiser AR, Singh P, Shanies HM. Sustained dapsone‐induced remission of hypocomplementemic urticarial vasculitis–a case report. Angiology 1997; 48:1019–22.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1019</start><end>22</end></extent></part><relatedItem type="host"><titleInfo><title>Angiology</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1019</start><end>22</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0136"><titleInfo><title>Idiopatic angioedema treated with dapsone</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Gonzalez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Soriano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Caballero</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Niveiro</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gonzalez P, Soriano V, Caballero T, Niveiro E. Idiopatic angioedema treated with dapsone. Allergol Immunopathol (Madr) 2005; 33:54–6.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>54</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Allergol Immunopathol (Madr)</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>54</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0137"><titleInfo><title>Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Engin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ozdemir</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Engin B, Ozdemir M. Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008; 22:481–6.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>481</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>J Eur Acad Dermatol Venereol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>481</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0138"><titleInfo><title>Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation</title></titleInfo><name type="personal"><namePart type="given">GE</namePart><namePart type="family">Reeves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Boyle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Bonfield</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Dobson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Loewenthal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004; 34:182–6.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>182</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Intern Med J</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>182</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0139"><titleInfo><title>Methotrexate‐responsive chronic idiopathic urticaria: a report of two cases</title></titleInfo><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Gach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Sabroe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Black</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gach JE, Sabroe RA, Greaves MW, Black AK. Methotrexate‐responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 2001; 145:340–3.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>340</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>340</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0140"><titleInfo><title>Methotrexate for urticarial vasculitis</title></titleInfo><name type="personal"><namePart type="given">PS</namePart><namePart type="family">Stack</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy 1994; 72:36–8.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>36</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>36</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0141"><titleInfo><title>Stanozolol in chronic urticaria: a double blind, placebo controlled trial</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Parsad</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Pandhi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Juneja</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 2001; 28:299–302.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>299</start><end>302</end></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>299</start><end>302</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0142"><titleInfo><title>Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema</title></titleInfo><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Engler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Squire</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Benson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Engler RJ, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995; 74:155–9.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>74</number></detail><extent unit="pages"><start>155</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Allergy Asthma Immunol</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>74</number></detail><extent unit="pages"><start>155</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0143"><titleInfo><title>Sulfasalazine in the treatment of corticosteroid‐dependent chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Jaffer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jaffer AM. Sulfasalazine in the treatment of corticosteroid‐dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991; 88:964–5.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>964</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>964</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0144"><titleInfo><title>Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine</title></titleInfo><name type="personal"><namePart type="given">LY</namePart><namePart type="family">McGirt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Vasagar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Gober</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SS</namePart><namePart type="family">Saini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Beck</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 2006; 142:1337–42.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>142</number></detail><extent unit="pages"><start>1337</start><end>42</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>142</number></detail><extent unit="pages"><start>1337</start><end>42</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0145"><titleInfo><title>Warfarin treatment of chronic idiopathic urticaria and angio‐oedema</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Parslew</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Pryce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ashworth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PS</namePart><namePart type="family">Friedmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio‐oedema. Clin Exp Allergy 2000; 30:1161–5.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1161</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1161</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0146"><titleInfo><title>Outpatient management of acute urticaria: the role of prednisone</title></titleInfo><name type="personal"><namePart type="given">CV</namePart><namePart type="family">Pollack Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TJ</namePart><namePart type="family">Romano</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pollack CV Jr, Romano TJ. Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 1995; 26:547–51.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>547</start><end>51</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Emerg Med</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>547</start><end>51</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0147"><titleInfo><title>H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Leurs</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Church</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Taglialatela</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leurs R, Church MK, Taglialatela M. H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32:489–98.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>489</start><end>98</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>489</start><end>98</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0148"><titleInfo><title>British guideline on the management of asthma</title></titleInfo><name type="corporate"><namePart>British Thoracic Society, Scottish Intercollegiate Guidelines Network</namePart></name><genre>journal-article</genre><note type="citation/reference">British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58(Suppl. 1):i1–94.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>i1</start><end>94</end></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>i1</start><end>94</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0149"><titleInfo><title>The effectiveness of montelukast for the treatment of anti‐histamine‐resistant chronic urticaria</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sanada</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Tanaka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kameyoshi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hide</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti‐histamine‐resistant chronic urticaria. Arch Dermatol Res 2005; 297:134–8.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>297</number></detail><extent unit="pages"><start>134</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol Res</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>297</number></detail><extent unit="pages"><start>134</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0150"><titleInfo><title>Comparative effects of fexofenadine and montelukast on allergen‐induced wheal and flare</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">White</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Rothrock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Meeves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Liao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Georges</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">White M, Rothrock S, Meeves S, Liao Y, Georges G. Comparative effects of fexofenadine and montelukast on allergen‐induced wheal and flare. Allergy Asthma Proc 2005; 26:221–8.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>221</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Proc</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>221</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0151"><titleInfo><title>Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled study</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Nettis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Colanardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Paradiso</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ferrannini</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled study. Clin Exp Allergy 2004; 34:1401–7.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1401</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Allergy</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1401</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0152"><titleInfo><title>The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single‐blind, placebo‐controlled, crossover clinical study</title></titleInfo><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Erbagci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single‐blind, placebo‐controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110:484–8.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>484</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>484</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0153"><titleInfo><title>Comparison of montelukast and fexofenadine for chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Nettis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Dambra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">D'Oronzio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Loria</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ferrannini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Tursi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001; 137:99–100.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>99</start><end>100</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>99</start><end>100</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0154"><titleInfo><title>Comparison of short‐ and long‐term cyclosporine A therapy in chronic idiopathic urticaria</title></titleInfo><name type="personal"><namePart type="given">EB</namePart><namePart type="family">Baskan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Tunali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Turker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Saricaoglu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baskan EB, Tunali S, Turker T, Saricaoglu H. Comparison of short‐ and long‐term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004; 15:164–8.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>164</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Dermatolog Treat</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>164</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cea12494-cit-0155"><titleInfo><title>Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Di Gioacchino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Di Stefano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Cavallucci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Di Gioacchino M, Di Stefano F, Cavallucci E et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003; 24:285–90.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>285</start><end>90</end></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Proc</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>285</start><end>90</end></extent></part></relatedItem></relatedItem><identifier type="istex">B0C8B3821312AA15B132DB68E888A4DEB918E679</identifier><identifier type="ark">ark:/67375/WNG-XFMDS0N2-H</identifier><identifier type="DOI">10.1111/cea.12494</identifier><identifier type="ArticleID">CEA12494</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2015 John Wiley & Sons Ltd© 2015 John Wiley & Sons Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-14</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XFMDS0N2-H/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002989 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002989 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:B0C8B3821312AA15B132DB68E888A4DEB918E679
|texte= BSACI guideline for the management of chronic urticaria and angioedema
}}
| This area was generated with Dilib version V0.6.33. |  |